North America Bioresorbable Polymers Market (2024-2029)
The North America Bioresorbable Polymers Market was valued at $169.5 Million in 2024 and projected to reach to $288.7 Million by 2029, representing a compound annual growth rate of 11.2%. North America's bioresorbable polymers market is positioned for sustained expansion, with the 11.2% CAGR reflecting strong demand from orthopedic surgeons, cardiologists, and surgical specialists adopting bioresorbable solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Bioresorbable Polymers Market Trends and Insights
- This 11.2% compound annual growth rate reflects North America's strong position in advanced medical device manufacturing and surgical applications.
- North America leads in adoption of bioresorbable materials across orthopedic implants, cardiovascular devices, and tissue engineering scaffolds, driven by stringent regulatory frameworks and high healthcare spending. The North America market benefits from established healthcare infrastructure, significant R&D investments, and a concentration of leading medical device manufacturers.
- North America's regulatory environment, particularly FDA approval pathways, has accelerated commercialization of innovative bioresorbable polymer solutions.
- Between 2024 and 2029, North America is expected to maintain its competitive advantage through continued innovation in polymer chemistry and expanding clinical applications in minimally invasive surgery and regenerative medicine..
Key Market Statistics
- CAGR (2024-2029) 11.2% CAGR
- Market Size, 2024 ~USD 169.5 Million
- Forecast, 2029 ~USD 288.7 Million
- Geography North America
North America Bioresorbable Polymers Market Overview
US Market Dominance :
The United States commands the North American bioresorbable polymers market with $224.9 million in 2024, driven by advanced healthcare infrastructure, high adoption of minimally invasive surgical procedures, and strong R&D investments in medical device innovation.
Orthopedic & Cardiovascular Leadership :
North America leads global adoption of bioresorbable materials in orthopedic implants, cardiovascular stents, and surgical sutures, supported by FDA approvals, reimbursement policies, and established clinical protocols for bioresorbable device applications.
Regulatory & Reimbursement Advantage :
Favorable FDA pathways, robust reimbursement frameworks, and established clinical evidence support rapid commercialization of bioresorbable polymer products in North America, accelerating market penetration compared to other regions.
Canada & Mexico Growth Potential :
Canada ($27.24M) and Mexico ($36.53M) represent emerging growth opportunities, with expanding medical device manufacturing capabilities, increasing healthcare spending, and growing adoption of advanced surgical technologies driving regional expansion.
North America Bioresorbable Polymers Market Dynamics
- The region benefits from mature healthcare systems, stringent quality standards, and continuous innovation in polymer chemistry and medical device design.
- Increasing prevalence of chronic diseases, aging populations, and preference for minimally invasive procedures further support market growth through 2029. Key drivers include FDA approvals for next-generation bioresorbable devices, expanding clinical applications beyond orthopedics into wound care and drug delivery, and strategic partnerships between material suppliers and medical device manufacturers.
- Investment in biocompatibility research and manufacturing scale-up will enhance product availability and reduce costs, making bioresorbable solutions more accessible across North American healthcare systems and driving market penetration in secondary and tertiary care facilities..
Related Ecosystem
Green Bio Chemicals
- Animal-Based Sealants
- Bacterial Fermentation
- Corrosion Inhibitors
- Hydrogen Peroxide
- Nitrile Butadiene Rubber (NBR)
- Basf se
- Evonik industries ag
- Solvay sa
- AZELIS HOLDINGS SA
- CARGILL, INCORPORATED
Resins And Polymers
- Polycarbonate
- Acrylonitrile Butadiene Styrene (ABS)
- Epoxy Resin
- Light Commercial Vehicles (LCVs)
- Polypropylene (PP)
- Basf se
- DOW CHEMICAL COMPANY
- Solvay sa
- Saudi arabia basic industries corporation (sabic)
- DuPont de Nemours, Inc.
Key Takeaways
- North America's bioresorbable polymers market is valued at $169.5 million in 2024 and will reach $288.7 million by 2029, representing 11.2% CAGR.
- North America dominates global adoption of bioresorbable materials in orthopedic implants, cardiovascular devices, and tissue engineering applications.
- North America's FDA regulatory framework and robust healthcare infrastructure accelerate commercialization and clinical adoption of bioresorbable polymer innovations.
- North America's market growth is driven by increasing demand for minimally invasive surgical solutions and regenerative medicine applications through 2029.
Bioresorbable Polymers Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PLGA (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.6% from 2024 to 2029 |
| Largest Segment | ORTHOPEDIC DEVICES (Application) |
| Market Size Base Year (Billions) | ~USD 0.5 (2024) |
| Revenue Forecast (Billions) | ~USD 0.87 (2029) |
| Segments Covered | Type, Application |
North America Bioresorbable Polymers Market Report Segmentation
2 segment dimensions are covered across the global market.
By Type
- Other Types
- Pcl
- Pga
- Pla
- Plga
- -Pdlla
- -Plla
By Application
- Drug Delivery
- Hip
- Knee
- Oral
- Orthopedic Devices
- Other Applications
- Other Drug Delivery Applications
- Other Orthopedic Device Applications
- Parenteral
- Spine
- Sports Injury
- Trauma
Target Audience
- Medical Device Manufacturers : Bioresorbable polymer producers and medical device companies need North America market data to identify growth segments, competitive positioning, regulatory requirements, and reimbursement strategies for orthopedic, cardiovascular, and surgical applications.
- Healthcare Investors & PE Firms : Investment professionals require detailed North American market sizing, growth projections, and country-level analysis to evaluate portfolio opportunities, assess acquisition targets, and make capital allocation decisions in the bioresorbable polymers sector.
- Pharmaceutical & Biotech Companies : Organizations developing drug delivery systems and combination products need North America market intelligence to understand bioresorbable polymer adoption, clinical acceptance, and partnership opportunities with device manufacturers and healthcare providers.
- Healthcare Providers & Hospital Systems : Surgeons, hospital procurement teams, and clinical administrators require market insights on bioresorbable device availability, clinical outcomes, cost-effectiveness, and reimbursement status to inform purchasing decisions and surgical protocol development.
- Material Science & Polymer Suppliers : Raw material suppliers and polymer manufacturers need North America market data to identify demand trends, customer requirements, production capacity planning, and strategic partnerships with medical device OEMs across the region.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 224.9 Million |
| Canada | USD 27.24 Million |
| Mexico | USD 36.53 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Quantified North America market data ($169.5M in 2024, $288.7M by 2029) with 11.2% CAGR provides concrete evidence of market expansion, enabling accurate financial forecasting and investment decision-making for stakeholders targeting this high-growth region.
- Country-Level Competitive Intelligence : Detailed breakdown of US ($224.9M), Canada ($27.24M), and Mexico ($36.53M) markets reveals competitive dynamics, market concentration, and regional opportunities for product positioning, market entry strategies, and partnership development.
- Application & End-User Insights : Comprehensive analysis of North American adoption patterns in orthopedic implants, cardiovascular devices, and surgical applications identifies high-demand segments, clinical adoption barriers, and reimbursement landscapes specific to regional healthcare systems.
- Regulatory & Reimbursement Landscape : North America-specific intelligence on FDA approval pathways, reimbursement policies, and clinical evidence requirements enables manufacturers to optimize product development timelines, accelerate commercialization, and navigate regional compliance requirements effectively.
- Strategic Growth Opportunities : Identification of emerging markets in Canada and Mexico, alongside mature US opportunities, provides diversified growth pathways for market expansion, manufacturing localization, and distribution network development across North America.
Frequently asked questions
What is the current size of North America's bioresorbable polymers market?
North America's bioresorbable polymers market was valued at $169.5 million in 2024 and is projected to grow to $288.7 million by 2029.
What is the expected growth rate for North America's bioresorbable polymers market?
North America's bioresorbable polymers market is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2029.
Which applications drive North America's bioresorbable polymers market?
North America's market is primarily driven by orthopedic implants, cardiovascular devices, surgical sutures, and tissue engineering scaffolds in minimally invasive procedures.
Why is North America a leading market for bioresorbable polymers?
North America leads due to advanced healthcare infrastructure, significant R&D investments, FDA regulatory support, and high adoption rates among medical device manufacturers.
What factors will support North America's bioresorbable polymers market growth through 2029?
Growth will be supported by increasing demand for minimally invasive surgery, regenerative medicine applications, aging population, and continuous polymer innovation in North America.
RESEARCH METHODOLOGY
The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:
Primary Research
The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION | |
|---|---|---|
| Evonik Industries AG | Sales Manager | |
| Ashland Global Holdings Inc. | R&D Manager | |
| KLS Martin Group | Global R&D Head | |
| DSM Biomedical | Business Development Manager | |
| Poly-Med Incorporated | Regional Sales Manager | |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The supply chain of the industry has been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
- All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.
Market Definition
The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.
Stakeholders
- Bioresorbable polymers manufacturers
- Bioresorbable polymers suppliers
- Raw material suppliers
- Application sector companies
- Government bodies
Report Objectives
- To define, describe, and forecast the bioresorbable polymers market in terms of value and volume
- To provide detailed information regarding the drivers, opportunities, restraints, and challenges influencing market growth
- To estimate and forecast the market size by type, application, and region
- To forecast the size of the market for five main regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
- To strategically analyze micromarkets1 with respect to their growth trends, prospects, and contribution to the overall market
- To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
- To analyze competitive developments, such as deals and expansions, in the market
- To strategically profile key players and comprehensively analyze their growth strategies
Get the Full Bioresorbable Polymers Market Report
Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.
- US Bioresorbable Polymers Market
- Canada Bioresorbable Polymers Market
- Mexico Bioresorbable Polymers Market
- Germany Bioresorbable Polymers Market
- UK Bioresorbable Polymers Market
- France Bioresorbable Polymers Market
- Italy Bioresorbable Polymers Market
- Russia Bioresorbable Polymers Market
- China Bioresorbable Polymers Market
- Japan Bioresorbable Polymers Market
- India Bioresorbable Polymers Market
- South Korea Bioresorbable Polymers Market
- Brazil Bioresorbable Polymers Market
- Argentina Bioresorbable Polymers Market
- Rest Of Europe Bioresorbable Polymers Market
- Rest Of Asia Pacific Bioresorbable Polymers Market
- Saudi Arabia Bioresorbable Polymers Market
- UAE Bioresorbable Polymers Market
- Rest Of South America Bioresorbable Polymers Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
